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ABSTRACT
Objective: The global burden and the high prevalence of diabetes mellitus in India signify the importance of its control with effective measures. 
Particularly, intestinal alpha-amylase and alpha-glucosidase enzyme inhibitors reduce postprandial hyperglycemia and play a key role in preventing 
diabetic complications. Herbal plants also possess greater antioxidant, enzyme inhibitory, and antihyperglycemic activities with minimal side effects. 
Hence, this study is done to elucidate the inhibition of alpha-amylase and alpha-glucosidase enzyme activity and antidiabetic potential of Calliandra 
haematocephala.
Methods: The leaves of C. haematocephala extracted by ethanol as a solvent were used to elucidate the blocking of alpha-amylase and alpha-glucosidase 
enzymes for antidiabetic effect, and the absorbance was measured using spectrophotometry. The percentage of inhibition and half maximal inhibitory 
concentration (IC50) value of the plant and control were calculated.
Results: The maximum percentage inhibition of C. haematocephala against alpha-amylase was 61% (IC50 value of 82.18 μg/ml) and alpha-glucosidase 
was 71% (31.07 μg/ml). The maximum percentage inhibition of acarbose against alpha-amylase was 92% (IC50 value of 42.65 μg/ml) and alpha-
glucosidase was 89% (62.28 μg/ml).
Conclusion: Hence, the above study proved the antidiabetic activity of C. haematocephala and its significant role in the pharmacotherapy of diabetes 
mellitus.
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INTRODUCTION
Diabetes mellitus presents with uncontrolled blood sugar levels due to 
lack of insulin or insulin resistance. For the past three decades, global 
prevalence of diabetes has almost doubled in the adult population, 
particularly in lower to middle socioeconomic group [1]. Hence, it is 
considered to be one of the four priority non-communicable diseases 
which are targeted for action. India shares the global diabetes 
burden because of early onset of disease, low awareness, and lifestyle 
modification [2]. Studies revealed the high prevalence of prediabetic 
state and rapid conversion of impaired glucose tolerance to diabetes in 
both South Indian urban and rural population [3]. Hence, the primary 
prevention and management are important because of rapid rise of 
vascular complications. Medicinal plants possess antidiabetic effect 
are used worldwide. They are effective in controlling plasma blood 
sugar and have minimal side effects. Considering the side effects of 
the antihyperglycemic drugs today, these plants could be a potential 
alternative or add-on drug and also reduce the economic burden. 
Moreover, the various chemical constituents target on different modes of 
mechanisms favor the treatment and prevention of complications [4,5].
The plant Calliandra haematocephala (red powder puff) is an evergreen 
deciduous and well-branched shrub with silky leaves. These shrubs are 
10–15’ (3–4.6 m) height and belong to the family Mimosaceae (Touch-
me-not family). Red powder puff has attractive soft round brushes 
shaped flowers which bloom from October to April. The plant has 
been used in traditional medicine because of its blood purifying, anti-
inflammatory, gastroprotective, hepatoprotective, immunomodulatory, 
and antiulcerogenic properties. The phytochemical investigations show 
the presence of tannins, flavonoids, and saponins which are responsible 
for these activities. Studies proved that betulinic acid is responsible 
for its antitumor, anti-HIV, anti-rotavirus activities, and gallic acid for 
antibacterial activity [6-11].
Alpha-amylase and alpha-glucosidase inhibitors are used for the drug 
therapy of diabetes mellitus by reducing postprandial hyperglycemia. 
Many plants possess significant alpha-amylase and alpha-glucosidase 
curbing potential depicted by protection of the crops by suppressing 
the digestion of carbohydrate and change the feeding pattern of 
insects [12]. Studies proved about the bioactivity of polyphenols in 
plants and its correlation with their antioxidant and hypoglycemic 
properties [13]. Synthetic inhibitors such as acarbose and miglitol 
cause so many gastrointestinal side effects. Hence, the plant-derived 
alpha-amylase and alpha-glucosidase inhibitors could be a vital target 
for type 2 diabetes mellitus with minimal side effects. The two enzymes 
alpha-amylase and alpha-glucosidase and their inhibition by the 
ethanol extract of the study plant C. haematocephala are the design we 
postulated as the aim of the study.
METHODS
The C. haematocephala leaves were obtained in and around Madipakkam 
area and certified by Prof. P. Jayaraman, from Plant Anatomy Research 
Centre of West Tambaram. (Reg No. PARC/2017/3442).
Sample extraction
Soxhlet apparatus was used to extract the powdered sample (25 g) of 
the plant with ethanol used as a solvent. The extract was condensed 
under reduced pressure in rotary vacuum evaporator and stored at 4°C.
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In vitro methods for antidiabetic activity
Determination of alpha-amylase inhibitory activity
The alpha-amylase inhibitory effects of the plant extracts were 
elucidated by the method of Rege and Chowdary, 2014 [14]. The assay 
mixture containing 200 μl of sodium phosphate buffer, 20 μl of enzyme, 
and 20 μl of extract was incubated for 10 min at room temperature 
followed by the addition of 200 μl of starch in all the tubes. The reaction 
was stopped with the addition of 400 μl of DNS reagent and kept in the 
boiling water bath for 5 min, cooled and diluted with 15 ml of distilled 
water and absorbance of the control, and the samples were measured 
at 540 nm. The control sample was devoid of the plant extract. The 
percentage inhibition was analyzed by the formula:
Calculation
Percentage inhibition (%)=Absorption of the control–Absorption of the 
sample/Absorption of the control×100.
Determination of alpha-glucosidase inhibitory activity
Reaction mixture containing 50 μl phosphate buffer, 10 μl alpha-
glucosidase, and 20 μl of varying concentrations of extracts was 
preincubated at 37°C for 15 min. Then, 20 μl p-nitrophenyl-α-D-
Glucopyranoside was added as a substrate and incubated further at 
PNPG for 30 min. The reaction was stopped by adding 50 μl sodium 
carbonate. The yellow color produced was observed at 405 nm. Each 
experiment was carried out along with appropriate blanks. Acarbose 
at various concentrations (20–100 μl/ml) was included as a standard. 
Negative control without extracts was set up in parallel. The result is 
expressed as percentage inhibition [15].
Calculation
Inhibition (%)=Absorption of the control - Absorption of the sample/
Absorption of the control×100.
50% inhibitory concentration (IC50) calculation [16]
The IC50 of the sample and control calculation=(AC-AS)/AC×100.
RESULTS
Alpha-amylase assay
The maximum inhibitory activity of the sample was 61% 
(C. haematocephala) and IC50 at around 82.18 μg/ml. Whereas, the 
maximum inhibitory activity of control (acarbose) was 92% and IC50 
was at around 42.65 μg/ml (Table 1). Then, the graph was plotted with 
the concentration of sample on X-axis and percentage of inhibition of 
alpha-amylase enzyme at Y-axis (Fig. 1).
Alpha-glucosidase assay
The sample showed inhibitory activity of 71% (C. haematocephala) and 
IC50 at around 31.07 μg/ml. Whereas, the maximum inhibitory activity 
of control (acarbose) was 89% and IC50 was at around 62.28 μg/ml 
(Table 2). Then, the graph was plotted with the concentration of sample 
on X-axis and percentage inhibition of alpha-glucosidase enzyme at 
Y-axis (Fig. 2).
Table 1: In vitro antidiabetic activity of C. haematocephala by 
alpha-amylase method and IC50 calculation of both sample and 
control (acarbose)











IC50 (μg/ml) 82.18 (μg/ml) 42.65(μg/ml)
C. haematocephala: Calliandra haematocephala, IC50: Half maximal inhibitory 
concentration
DISCUSSION
Postprandial hyperglycemia is the important key factor for glycemic 
control and predictor of micro- and macro-vascular complications 
in diabetes mellitus [17]. Drugs which inhibit the alpha-amylase 
and alpha-glucosidase enzymes and reduce the postprandial 
hyperglycemia could be a novel approach for this metabolic disorder. 
These drugs inhibit the conversion of postprandial starch into 
simple glucose and its intestinal absorption. In addition to it, alpha-
Fig. 2: In vitro antidiabetic activity of Calliandra haematocephala 
by alpha-glucosidase method and half maximal inhibitory 
concentration calculation of both sample and control (acarbose)
Table 2: In vitro antidiabetic activity of C. haematocephala by 
alpha-glucosidase method and IC50 calculation of both sample 
and control (acarbose)











IC50 (μg/ml) 31.07 (μg/ml) 62.28 (μg/ml)
C. haematocephala: Calliandra haematocephala, IC50: Half maximal inhibitory 
concentration
Fig. 1: In vitro antidiabetic activity of Calliandra haematocephala 
by alpha-amylase method and half maximal inhibitory 
concentration calculation of both sample and control (acarbose)
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glucosidase inhibitors increase the release of the glucoregulatory 
hormone glucagon-like peptide-1 (GLP-1) into the circulation which 
contributes the glucose-lowering effect further [18]. Hence, they are 
effective as GLP-1 analogs and play in major therapeutic intervention 
of Type 2 diabetes mellitus. Acarbose, miglitol, and voglibose are 
used in newly diagnosed Type 2 diabetes and as a add-on drug with 
sulfonylureas and metformin to control the postprandial surge. 
However, gastrointestinal side effects are more with these synthetic 
inhibitors [19].
Herbal medicines have been used successfully in managing diabetes 
because of its ready availability, lesser side effects, and cost-
effectiveness. Plants are good inhibitors of alpha-amylase and alpha-
glucosidase and also have insulin-like activity [12]. In diabetes, 
increased lipid peroxidation leads to significant structural changes 
and alters lipid metabolism. Chronic hyperglycemia increases the 
production of reactive oxygen species that leads to the vascular 
complications through lipid peroxidation [20]. It is established that 
plant-derived bioactive phytochemicals have antidiabetic potential 
and reduce hyperglycemia. Hence, plants possess both antioxidant and 
antidiabetic properties could be a novel approach to prevent diabetic 
complications [21,22]. Docking studies also proved and isolated the 
active ingredients from the promising antidiabetic plants [23].
Flavonoids particularly isoquercitrin inhibit the sodium-dependent 
glucose uptake in the intestinal mucosa through sodium-dependent 
glucose transporter-1, delay the gastric emptying, stimulating glucose 
transporter 4 expression in skeletal muscles, and increase insulin 
sensitivity [24,25]. The antioxidant and anti-inflammatory actions 
of flavonoids protect the blood vessels and prevent the micro- and 
macro-vascular complications. Myricetin also possesses antioxidant, 
anti-inflammatory, and ameliorates insulin resistance [26]. One study 
showed that the leaves and bark of Calliandra surinamensis a different 
species of Calliandra were assessed for antidiabetic potential and found 
to be effective [27]. The phytochemical analysis of the C. haematocephala 
leaves extract shows the presence of alkaloids, tannins, flavonoids, 
saponin, and glycosides. It is proved that flavonoids, tannins, and 
glycosides isolated from C. haematocephala found to possess greater 
antioxidant activities [28]. Compounds such as myricetin and quercetin 
isolated from bark and leaves of C. haematocephala are found to possess 
strong radical scavenging properties [29,30]. Moreover, several studies 
supported the positive correlation of antioxidant properties with alpha-
amylase and alpha-glucosidase inhibitory activities [12,13]. Hence, 
the antioxidant and alpha-amylase and alpha-glucosidase enzyme 
inhibitory properties ideally support the antihyperglycemic activity of 
C. haematocephala.
CONCLUSION
Hence, this study proved the antihyperglycemic activity and 
antidiabetic potential of C. haematocephala in type 2 diabetes mellitus. 
In comparison to synthetic alpha-glucosidase enzyme inhibitors, this 
plant could be a better alternative or adjuvant by increasing the efficacy 
of other antidiabetic drugs. However, isolating the compound which is 
responsible for the enzyme inhibitory activity would be a better lead 
and adjuvant in the control of diabetes mellitus.
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